Metraipolis › archive › dc_d620d72bef5c

Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007180
DOI
10.3390/bioengineering12090935
License (as archived)
solo-consultazione
Archived
2026-11-10T06:20:40.948Z
SHA-256 of the archived text
e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1
Stable URL of this page
https://metraipolis.com/documento/dc_d620d72bef5c

How to cite

Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180 — Europe PMC (en), https://europepmc.org/article/MED/41007180 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d620d72bef5c (Metraipolis archive dc_d620d72bef5c, sha256 e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1)
BibTeX
@misc{dcd620d72bef5c,
  title = {Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007180},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d620d72bef5c; sha256 e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007180. Agents can read the archived copy with the MCP tool read_document.